hg_12187.1

Basic information about the TSS

---

TSS ID: hg_12187.1 Species: human Chr: chr1		Start: 46616804 End: 46616819 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000531769.6 AK304005 Distance: -24 GeneID: 8569 HGNC/MGI_ID: HGNC:7110 UniProt_ID: B4E1V9 E9PSE0

Gene_name: MAPK interacting serine/threonine kinase 1 Gene_symbol: MKNK1 Gene_synonyms: MNK1 Gene_source: HGNC:7110

TATA-Box annotation

---

Distance to TSS:	79
Nearest PromoterID:	NM_201403
Entrez ID:	148932
Nearest Unigene:	Hs.632401
Nearest Refseq:	NM_145279
Nearest Ensembl:	ENSG00000142961
Gene Name:	MAPK interacting serine/threonine kinase 1
Gene Alias:	MOB1E|MOBKL2C
Gene Description:	MOB kinase activator 3C
Gene Type:	protein-coding
CpG%:	0.095
GC%:	0.731343
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MKNK1 p2@MKNK1 p3@MKNK1 p4@MKNK1
Sample		p1@MKNK1	p2@MKNK1	p3@MKNK1	p4@MKNK1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.71	0.00	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.12	0.00	0.00	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	10.42	0.00	0.00	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.07	0.21	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.55	0.22	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.50	0.00	0.58	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	14.16	0.22	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	12.11	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	11.54	0.00	0.00	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.23	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.72	0.40	0.40	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	9.76	0.41	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.32	1.29	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.47	0.75	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.27	1.10	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.28	0.00	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	2.40	0.44	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	3.37	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2.13	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	5.12	1.65	0.60	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.55	0.94	0.67	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	4.49	1.73	0.86	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.39	0.78	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	4.61	0.24	1.94	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	3.61	1.29	2.06	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	3.80	0.95	1.90	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	2.75	0.55	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	6.13	1.18	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	4.36	1.45	1.13	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	5.25	1.27	2.71	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	3.56	1.05	2.09	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	5.86	0.98	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	4.43	1.06	2.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	5.94	0.82	1.15	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	4.86	0.37	1.12	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	4.22	0.96	1.34	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	4.70	0.82	1.64	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	4.84	1.61	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	4.59	1.08	2.16	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.00	1.68	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.71	1.65	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	6.15	0.88	1.46	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.33	0.63	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3.85	0.70	1.05	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.62	1.41	1.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	5.35	1.63	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.00	2.64	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.75	3.87	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	5.74	0.72	1.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.86	2.22	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.35	2.05	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.56	1.11	1.78	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.10	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	4.97	0.99	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	2.52	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	0.92	2.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.16	1.30	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	6.74	0.96	1.28	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.06	1.26	1.26	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	5.64	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.85	1.12	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.19	1.02	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.15	1.95	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.32	0.71	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.31	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	4.96	1.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2.81	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.64	2.32	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.02	0.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3.06	1.83	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	8.71	1.58	0.63	0.95
Adipocyte - breast, donor2	11327-117E4	7.22	1.93	0.64	0.32
Adipocyte - omental, donor1	11473-119C6	7.00	1.78	1.65	0.51
Adipocyte - omental, donor2	11474-119C7	9.72	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	10.72	0.67	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	10.21	1.28	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.97	1.35	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.30	4.34	1.39	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	15.84	3.13	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	14.16	2.57	1.03	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	12.54	1.67	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	14.11	2.35	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	14.88	5.23	4.34	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	17.11	2.90	3.23	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	11.20	3.73	4.80	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	7.23	3.34	4.45	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	9.98	3.33	3.33	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	11.55	2.51	3.52	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	9.82	3.93	3.60	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	11.57	3.65	4.26	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	10.39	1.77	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	7.53	1.43	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	10.97	1.44	1.98	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.22	2.05	2.26	0.00
Anulus Pulposus Cell, donor1	11248-116E6	6.64	2.06	0.23	1.26
Anulus Pulposus Cell, donor2	11463-119B5	8.33	1.96	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.64	1.80	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.91	0.87	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.17	1.20	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	3.57	0.00	0.65	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.83	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	3.56	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.27	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	4.35	0.00	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.61	0.99	0.99	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.67	0.90	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.29	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.72	0.76	0.57	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.08	1.60	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.64	0.83	0.83	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.29	1.20	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.74	1.94	0.97	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.07	1.52	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	1.21	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	1.71	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.92	0.64	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.87	0.52	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	5.16	0.47	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	3.86	0.32	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.85	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.52	1.81	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	3.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	3.56	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.88	0.51	0.76	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	2.54	1.27	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.90	1.29	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.35	1.06	0.42	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.80	0.87	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.41	0.51	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	0.00	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.57	1.29	1.29	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.82	3.01	3.01	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.29	0.92	1.38	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.10	1.27	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	3.72	1.65	1.86	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.59	0.61	0.92	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.69	0.00	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.54	1.11	0.89	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.98	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.30	1.32	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.27	0.73	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	11.91	2.58	0.49	0.37
Astrocyte - cerebellum, donor2	11580-120F5	9.93	0.51	0.68	0.51
Astrocyte - cerebellum, donor3	11661-122F5	8.18	2.52	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	12.20	2.09	0.35	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	11.49	2.10	1.13	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	12.38	1.04	0.45	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	13.65	4.24	1.03	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	12.28	2.63	0.88	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	11.61	2.73	1.71	0.57
Basophils, donor1	12241-129G9	20.40	6.80	3.66	0.26
Basophils, donor2	12242-129H1	23.09	7.58	6.13	1.08
Basophils, donor3	12243-129H2	17.05	6.03	3.38	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	9.06	3.02	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	10.52	1.83	2.29	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	2.51	3.14	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	12.89	2.29	1.87	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	11.98	1.15	1.15	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	10.62	1.62	2.70	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	10.00	0.10	0.00	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	11.65	0.93	0.47	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	14.71	2.24	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	20.29	8.45	4.51	0.00
CD14+ Monocytes, donor2	11305-117B9	18.37	6.12	4.64	0.37
CD14+ Monocytes, donor3	11381-118B4	22.61	9.44	5.49	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	62.84	8.49	3.11	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	49.66	6.44	1.90	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	67.39	7.23	1.64	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	29.20	6.22	5.78	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	32.29	4.22	4.22	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	30.09	8.53	3.08	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	19.75	7.03	11.05	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	18.22	6.35	4.97	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	20.08	9.67	6.45	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	19.97	8.81	20.75	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	23.68	8.37	9.61	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	20.46	10.45	8.71	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	16.39	6.32	5.15	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	16.37	5.28	1.58	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	23.30	11.09	3.33	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	23.35	5.06	4.91	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	25.54	3.59	3.99	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	27.07	7.08	6.25	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	24.48	7.32	10.98	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.68	5.20	4.52	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	17.02	3.49	7.86	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.82	11.57	13.45	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	27.39	9.94	8.90	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	32.82	8.84	10.94	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	14.70	10.84	11.39	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.39	7.05	10.57	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.36	11.85	15.36	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.05	10.81	10.46	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	26.39	9.29	6.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	28.88	11.64	13.58	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.02	20.88	17.61	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.91	9.27	10.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.17	13.46	15.54	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	30.73	4.14	2.62	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	25.18	4.85	1.39	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	26.64	3.90	2.82	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	39.24	5.14	2.02	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	30.56	3.32	1.05	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	41.92	4.01	2.90	1.56
CD14-CD16+ Monocytes, donor1	11790-124B8	21.43	4.85	2.04	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	21.74	3.51	2.20	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	22.74	3.58	2.74	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	6.10	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	4.07	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	14.50	7.25	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	12.79	6.93	4.26	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	14.47	4.82	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	16.85	4.91	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	9.41	4.71	6.27	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	5.27	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	13.97	4.11	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	10.16	5.80	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	12.12	3.03	1.01	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	60.61	10.91	18.99	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	53.93	12.38	17.18	0.80
CD34+ Progenitors, donor1	11545-120B6	7.03	1.00	4.02	0.00
CD34+ Progenitors, donor2	11625-122B5	6.74	2.81	2.81	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	16.53	4.13	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	24.80	1.80	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	13.93	5.00	1.43	0.00
CD4+ T Cells, donor2	11306-117C1	12.25	6.12	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	13.42	3.96	3.05	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	24.76	7.15	1.02	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	20.44	4.04	1.12	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.83	5.75	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	15.17	3.32	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	11.94	5.62	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	28.47	7.51	1.88	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	27.62	6.95	4.07	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.27	6.61	4.19	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.07	4.03	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	14.67	3.49	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	18.48	5.72	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.88	4.22	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	29.92	7.27	1.87	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.09	4.01	2.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	12.51	2.99	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	18.22	5.90	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	19.73	0.00	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	33.38	7.23	1.48	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.56	7.58	2.60	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	35.94	7.57	5.04	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.18	6.57	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	12.56	5.63	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	24.41	4.36	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	18.81	3.96	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	31.39	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	11.17	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	29.91	10.52	1.38	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	41.47	7.61	1.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	23.10	12.32	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	27.22	11.10	1.79	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	23.54	8.31	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	24.55	8.51	5.24	0.65
CD8+ T Cells, donor2	11307-117C2	13.14	8.63	6.01	0.00
CD8+ T Cells, donor3	11383-118B6	21.21	6.82	4.80	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.59	1.61	1.15	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.51	0.96	1.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.20	0.55	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.30	0.90	1.20	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.60	2.40	1.20	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.55	2.27	1.36	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.00	1.09	1.52	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.53	1.58	0.79	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.92	1.17	1.41	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.04	1.21	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.20	1.74	1.16	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	4.53	0.53	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	5.69	2.63	6.13	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	6.38	1.37	4.55	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1.49	0.75	5.97	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.84	2.52	2.88	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	5.47	2.59	4.03	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.01	1.89	0.94	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4.12	1.27	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	5.84	2.15	2.15	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.09	1.60	1.92	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5.74	1.53	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.91	2.36	1.58	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.86	0.00	6.42	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.90	4.20	3.50	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	9.02	1.00	5.01	0.00
Cardiac Myocyte, donor1	11525-119I4	14.62	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	6.42	0.99	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	6.10	1.68	0.53	0.74
Chondrocyte - de diff, donor1	11261-116G1	10.05	1.39	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	6.75	2.13	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	6.83	1.82	0.34	0.57
Chondrocyte - re diff, donor2	11339-117F7	12.53	1.79	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	6.47	5.26	1.21	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	10.44	2.64	1.61	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	7.48	1.07	0.43	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	7.35	1.95	0.62	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.74	5.96	2.75	2.75
Corneal Epithelial Cells, donor1	11526-119I5	9.44	3.29	1.98	0.44
Corneal Epithelial Cells, donor2	11606-120I4	9.10	3.41	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	15.59	3.83	2.30	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.14	4.62	10.73	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	54.57	5.68	10.41	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	82.82	3.45	10.35	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	57.56	4.97	12.74	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	15.37	3.07	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	14.36	3.26	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	18.87	1.45	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	11.34	1.17	1.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	9.62	1.41	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.90	1.97	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	11.34	0.58	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	9.88	1.18	0.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	9.99	0.88	0.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.31	2.66	1.11	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	10.95	4.26	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.43	2.26	2.26	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	11.89	1.19	2.97	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	10.41	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	13.33	2.69	2.13	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	10.40	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	7.86	3.14	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	14.79	2.11	1.37	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.56	2.17	1.74	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	13.07	1.34	1.10	0.49
Endothelial Cells - Vein, donor1	11267-116G7	14.79	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	6.99	0.70	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.52	0.79	0.79	0.31
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	204.63	31.35	46.21	0.00
Eosinophils, donor3	12246-129H5	114.14	21.40	17.83	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.57	1.95	1.22	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	6.98	1.23	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.94	1.09	0.44	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.96	1.52	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	8.37	1.09	0.61	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	17.88	3.28	1.50	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.44	1.48	1.05	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	17.13	0.53	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	5.98	1.66	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	9.53	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	8.34	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	4.26	0.63	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	12.43	4.55	0.30	0.91
Fibroblast - Cardiac, donor5	11456-119A7	8.63	1.40	1.52	0.13
Fibroblast - Cardiac, donor6	11460-119B2	9.10	0.45	0.76	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.72	5.23	2.28	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	3.02	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	10.15	1.38	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	9.16	2.54	1.70	0.85
Fibroblast - Dermal, donor1	11269-116G9	5.87	0.23	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	9.43	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	5.68	1.33	0.24	0.24
Fibroblast - Dermal, donor4	11450-119A1	8.70	0.79	0.34	0.34
Fibroblast - Dermal, donor5	11454-119A5	8.90	1.74	0.52	0.52
Fibroblast - Dermal, donor6	11458-119A9	10.72	1.79	0.32	0.65
Fibroblast - Gingival, donor1	11237-116D4	11.45	5.21	0.83	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	15.98	4.19	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	9.88	2.50	1.05	0.26
Fibroblast - Gingival, donor3	11394-118C8	8.90	2.80	0.29	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	6.23	1.04	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.63	1.76	0.53	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	14.19	3.43	1.40	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.28	3.25	1.89	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.82	2.47	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	12.58	2.78	0.88	1.90
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	9.27	3.00	1.91	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	11.30	1.54	1.76	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	12.91	2.20	0.88	0.44
Fibroblast - Lung, donor1	11270-116H1	1.36	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	4.48	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	5.91	1.27	0.63	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	14.16	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.36	1.12	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	11.77	2.84	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	11.98	3.99	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.38	2.52	0.58	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	13.95	2.28	0.61	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	13.16	3.06	1.53	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.83	0.38	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.58	1.62	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	9.16	3.36	1.16	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	6.52	0.66	0.11	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	11.79	3.66	0.81	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	2.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.51	1.19	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	24.81	1.98	2.98	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	12.26	1.60	0.89	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	10.05	1.58	0.59	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	14.14	0.30	0.30	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.33	2.27	0.97	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.22	3.04	1.01	0.51
Fibroblast - skin normal, donor1	11553-120C5	9.02	2.30	0.82	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	11.43	1.40	0.60	0.40
Fibroblast - skin normal, donor2	11561-120D4	10.15	1.51	0.20	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	21.76	4.23	0.60	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	8.86	3.15	0.83	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.21	4.96	1.37	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.42	0.33	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	10.97	2.13	0.53	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	11.81	1.69	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.25	0.78	0.63	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	21.79	6.10	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	16.64	4.85	6.59	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	18.22	3.38	4.68	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	19.16	3.83	4.09	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	2.30	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.74	0.64	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	12.55	0.00	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	5.52	1.10	1.38	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	6.16	0.46	0.46	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	9.91	0.20	0.00	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.61	0.00	0.26	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2.94	0.33	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	11.50	0.00	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	6.22	0.28	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.40	0.74	0.12	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	3.49	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	10.53	1.24	0.50	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	10.24	0.97	0.28	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	6.10	0.00	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	10.27	1.83	0.91	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	10.34	1.37	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	7.87	0.87	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	11.82	1.48	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	10.81	1.43	0.32	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	7.15	0.22	1.34	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	8.87	1.41	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	10.52	1.87	0.85	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	8.87	0.71	0.62	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	11.24	1.77	0.52	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	9.39	1.88	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	11.40	1.44	0.22	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	9.32	1.00	0.50	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	9.19	1.63	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	8.25	0.83	1.03	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	10.03	2.19	0.46	1.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	10.17	2.17	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.38	1.76	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	10.33	1.35	0.49	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	10.70	0.49	0.65	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	10.26	2.25	0.96	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.42	1.42	0.19	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	9.65	0.63	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.43	1.22	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	11.60	1.67	0.63	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	8.56	1.32	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	6.17	1.96	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.39	1.76	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.36	2.67	0.00	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	9.79	1.22	0.46	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	8.94	0.52	0.65	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	8.67	2.17	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	12.72	0.74	0.92	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	9.43	1.97	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	6.94	2.98	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	8.05	2.64	0.92	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	7.26	1.21	0.61	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	9.15	2.29	0.51	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.17	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5.24	0.15	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	7.36	0.20	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.95	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	6.22	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	9.69	0.00	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.44	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	0.00	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	12.17	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	10.74	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	12.35	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.70	0.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	11.77	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.03	0.84	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	13.04	0.95	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.89	0.34	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	9.74	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	7.70	0.89	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	11.60	1.24	0.41	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.05	1.15	0.00	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.76	1.15	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.78	0.98	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	0.67	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.17	2.31	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	10.95	0.68	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.44	0.94	0.47	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.64	3.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.79	1.53	2.03	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.17	1.20	0.40	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	7.89	1.97	1.48	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	10.62	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	14.59	1.17	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	7.46	2.19	2.63	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	8.48	3.39	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	7.16	1.79	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	6.79	0.97	1.46	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	6.85	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.90	3.74	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	7.87	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.15	3.17	1.59	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.85	1.67	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.39	1.04	0.46	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.87	0.34	0.51	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.74	0.68	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	13.66	0.44	0.77	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.68	1.72	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.98	0.86	0.43	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.96	0.62	0.62	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.41	0.51	0.51	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.81	0.64	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.87	2.24	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.79	1.30	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	5.29	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9.52	4.23	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.90	2.91	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.74	0.70	0.70	0.35
Hepatocyte, donor1	11523-119I2	24.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	18.31	4.31	1.08	0.00
Hepatocyte, donor3	11684-122I1	19.63	1.84	3.07	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	41.12	0.65	0.00	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	8.04	1.22	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	7.27	1.23	0.14	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	29.24	3.25	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	5.29	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	19.96	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.23	2.52	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.26	1.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	16.30	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.11	1.68	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	0.80	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	1.85	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.52	1.42	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	21.77	0.00	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	9.69	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	25.41	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	26.14	1.91	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	14.28	1.43	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.75	0.62	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	35.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.25	4.87	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	4.43	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	11.34	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	1.07	1.07	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	14.73	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	25.38	3.17	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	10.61	3.02	3.67	0.33
Keratinocyte - epidermal, donor2	11349-117G8	11.13	1.76	1.76	0.00
Keratinocyte - epidermal, donor3	11421-118F8	14.58	1.99	2.65	0.09
Keratinocyte - oral, donor1	11251-116E9	13.51	3.97	2.72	0.79
Keratocytes, donor1	11527-119I6	17.54	3.09	0.69	0.00
Keratocytes, donor2	11607-120I5	16.41	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	9.48	1.38	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	4.40	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	8.63	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	8.19	2.54	1.27	1.27
Lens Epithelial Cells, donor3	11690-122I7	5.25	1.51	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9.25	2.13	0.83	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.86	1.95	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.97	1.57	0.79	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.14	0.54	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	0.32	1.26	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.98	0.97	0.54	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.57	0.82	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.55	0.76	1.01	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.71	1.41	0.84	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	1.19	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.79	0.97	0.97	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.41	1.30	0.93	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.32	0.70	1.74	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.16	1.91	0.95	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.79	1.37	1.10	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.24	2.77	2.46	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.92	1.25	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.53	1.10	1.10	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.20	0.99	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.56	0.00	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.46	1.74	1.99	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	1.45	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.35	0.81	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.87	1.67	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	1.04	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.03	1.05	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.17	1.80	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	4.14	2.26	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.97	2.12	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.78	1.45	1.94	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.66	1.73	0.99	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.00	1.48	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.95	1.98	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.56	2.20	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.08	1.29	2.25	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.78	2.43	1.22	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.24	2.66	2.52	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.82	0.36	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.94	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.87	2.49	1.40	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.80	1.07	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.86	0.98	0.98	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.53	1.41	0.94	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.02	1.86	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.35	2.05	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.93	1.19	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.18	1.53	4.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	12.62	2.97	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.62	2.12	4.23	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	1.41	4.22	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	0.00	6.54	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	1.03	2.06	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	2.38	3.57	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.99	2.26	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	14.83	0.87	4.94	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.31	3.60	4.05	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	13.55	3.66	4.20	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	15.41	1.03	5.14	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	1.76	2.47	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.99	0.00	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.73	1.53	8.66	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.01	3.74	4.80	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	18.52	3.02	7.18	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.34	2.45	5.52	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	2.45	5.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.45	3.12	8.33	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.97	3.92	8.41	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	14.42	2.06	4.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	18.29	2.90	8.42	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.37	4.19	8.07	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.62	2.21	7.75	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.14	2.47	6.36	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.86	2.58	4.79	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	2.30	6.91	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	17.27	3.07	7.68	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	17.55	5.66	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	2.46	6.56	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	20.79	1.36	6.78	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	2.15	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.18	3.73	3.73	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.61	3.34	5.95	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.21	1.29	9.48	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	1.71	7.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.99	2.00	4.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.27	1.81	4.22	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	16.35	0.71	4.98	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	16.15	3.78	5.84	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.03	4.83	2.68	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	15.49	2.69	2.69	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	15.19	4.07	5.93	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	0.00	9.30	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	1.06	5.29	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.41	4.00	8.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	20.35	2.91	8.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	4.60	3.83	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	21.21	3.95	5.43	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	3.76	7.53	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	16.09	1.01	5.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	24.78	2.70	7.21	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	1.72	8.61	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	18.26	2.23	6.68	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.03	3.13	7.82	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	16.49	1.98	6.60	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	19.20	1.04	10.38	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	17.50	2.63	8.31	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.89	5.03	10.62	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.99	3.53	13.69	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.04	3.47	11.19	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	8.61	2.53	16.20	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.98	0.96	12.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.88	3.58	13.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	14.58	4.25	13.98	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	4.15	4.15	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	19.76	4.18	13.30	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.56	5.16	16.01	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.91	2.42	7.26	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	13.94	5.70	15.21	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.99	6.40	12.79	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.19	2.87	10.34	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	15.94	4.63	14.91	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	17.68	4.24	16.27	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	17.59	2.84	7.38	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.81	6.24	12.90	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9.40	4.70	6.26	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.03	2.92	5.85	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.98	2.79	7.43	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.70	4.01	3.35	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.90	1.60	3.74	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	16.57	4.04	5.25	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	17.44	4.59	5.51	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	2.67	3.56	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.68	3.42	5.70	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.10	5.37	3.07	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.25	0.00	3.83	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.94	4.01	4.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.12	2.08	4.16	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	12.60	4.64	5.30	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	84.56	6.84	8.89	0.91
Macrophage - monocyte derived, donor2	11313-117C8	39.82	4.77	4.59	0.92
Macrophage - monocyte derived, donor3	11389-118C3	53.35	3.67	5.90	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.40	3.72	2.12	0.00
Mallassez-derived cells, donor2	11929-125I3	20.44	3.33	2.06	0.32
Mallassez-derived cells, donor3	11930-125I4	23.21	3.61	2.22	0.28
Mammary Epithelial Cell, donor1	11273-116H4	11.36	2.79	2.39	0.50
Mammary Epithelial Cell, donor2	11350-117G9	13.32	1.74	2.03	0.87
Mammary Epithelial Cell, donor3	11422-118F9	11.47	2.24	1.50	0.50
Mast cell - stimulated, donor1	11487-119E2	28.47	6.10	13.56	0.00
Mast cell, donor1	11563-120D6	48.01	18.28	40.99	0.65
Mast cell, donor2	11565-120D8	14.86	5.94	5.05	0.59
Mast cell, donor3	11566-120D9	19.81	6.08	3.38	1.13
Mast cell, donor4	11567-120E1	15.07	8.33	3.19	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	22.62	7.43	7.65	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	14.59	6.42	5.25	1.75
Mast cell, expanded, donor5	11939-126A4	26.39	6.54	7.11	0.69
Mast cell, expanded, donor8	11941-126A6	30.13	9.37	13.72	0.33
Melanocyte - dark, donor1	11502-119F8	11.94	2.49	1.59	0.10
Melanocyte - dark, donor2	11582-120F7	6.92	1.38	2.08	0.35
Melanocyte - dark, donor3	11663-122F7	7.68	2.03	1.01	0.87
Melanocyte - light, donor1	11274-116H5	7.52	1.18	0.71	0.47
Melanocyte - light, donor2	11351-117H1	4.09	2.05	0.00	0.68
Melanocyte - light, donor3	11423-118G1	5.20	0.87	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	7.81	1.77	0.94	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	10.22	0.81	0.54	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	12.59	2.41	0.80	0.54
Meningeal Cells, donor1	11493-119E8	13.03	2.36	1.49	0.37
Meningeal Cells, donor2	11573-120E7	9.24	2.20	0.44	0.00
Meningeal Cells, donor3	11654-122E7	7.09	1.55	0.90	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	8.84	2.85	0.86	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.35	0.91	0.81	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	2.63	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.20	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.95	2.33	0.64	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.58	3.02	4.02	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.91	1.54	0.66	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	0.00	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.21	1.64	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.60	1.11	0.42	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	3.72	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	6.71	1.58	0.66	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.31	1.19	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	5.12	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.03	3.19	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	8.44	2.81	1.56	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	9.81	2.39	3.45	0.00
Mesothelial Cells, donor2	12156-128G5	8.01	0.50	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	8.89	2.24	1.59	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	56.71	1.35	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	65.26	5.17	6.16	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	42.40	4.12	4.71	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	0.00	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	56.72	2.79	8.99	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	35.89	3.32	4.77	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	4.63	16.21	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	56.81	5.26	12.51	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	44.22	4.19	11.17	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	44.50	6.10	15.44	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	47.12	5.15	8.32	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	25.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	49.56	1.77	21.24	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	31.91	6.08	10.64	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	7.90	25.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	43.08	5.09	22.92	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	26.70	6.45	13.81	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.05	6.86	24.14	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	23.47	5.03	18.44	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	101.85	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	39.39	8.03	26.34	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	30.90	8.32	17.11	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.56	7.74	28.75	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	38.68	7.37	27.63	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	31.13	7.99	21.88	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.78	7.13	26.70	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	36.90	6.22	19.74	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.79	7.78	18.89	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	20.64	20.64	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	25.19	7.23	24.31	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.74	7.10	19.26	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	6.63	28.17	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	26.64	8.97	24.19	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	24.70	7.94	22.64	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	4.36	18.54	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.70	4.81	14.42	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	30.82	6.40	21.21	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	10.97	21.94	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	20.02	5.51	13.52	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	22.42	4.08	6.12	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	27.59	4.38	14.89	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	6.62	13.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.81	5.76	14.73	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.57	6.45	13.14	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	24.36	0.70	12.53	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	19.89	17.68	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.98	5.47	10.26	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	26.69	6.13	11.38	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	23.44	4.62	6.04	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	30.58	7.57	10.10	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	36.99	4.16	7.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.07	4.08	4.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	24.43	4.52	9.05	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.97	7.10	9.18	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	21.66	14.44	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	3.69	6.46	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	29.59	2.85	13.09	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	26.95	3.04	4.97	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	26.17	3.63	9.33	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	29.60	4.29	6.01	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	15.24	2.54	9.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.55	2.94	5.34	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	52.98	8.98	9.88	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.60	2.68	3.96	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.75	2.87	10.51	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	34.50	4.64	9.51	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.93	4.93	4.93	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	24.15	4.55	8.52	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.46	4.42	8.60	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.89	2.61	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	33.23	4.70	5.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	45.27	5.77	9.51	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	35.86	3.30	3.30	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.99	4.17	5.36	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	71.57	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	42.77	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	73.27	2.63	2.63	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	54.70	4.21	5.26	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	39.14	5.73	3.16	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	49.36	2.79	2.79	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	87.50	3.38	7.89	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	35.69	2.66	3.20	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	50.10	5.77	5.20	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	53.04	2.95	4.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	68.89	2.56	3.30	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	3.11	7.78	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	41.15	4.81	2.67	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	3.86	30.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	51.51	5.05	6.06	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.97	3.79	6.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	4.09	16.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.89	0.64	2.54	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	19.44	0.81	4.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	0.00	15.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	22.84	79.94	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	0.00	81.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	4.75	28.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	125.49	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	8.40	1.72	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.59	1.05	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	9.70	0.19	0.95	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	1.84	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.04	0.70	0.70	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.59	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.99	0.84	0.42	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	0.50	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.50	1.35	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.53	0.45	0.68	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.39	0.65	0.33	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.29	1.09	0.36	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	0.00	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.85	1.97	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.39	0.65	0.16	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	6.88	1.76	0.35	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	0.70	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3.68	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	5.14	0.64	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	13.80	1.03	0.69	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	40.46	5.06	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.24	2.45	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	1.69	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	3.80	0.71	0.24	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.58	0.86	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.00	1.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.51	1.35	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.76	1.19	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	0.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.68	1.89	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.19	0.98	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	2.18	0.00	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	4.98	1.36	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	0.66	0.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.44	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.83	0.38	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.91	4.54	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.06	0.88	1.55	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1.36	0.68	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	5.11	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.10	1.22	0.61	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.15	0.94	0.31	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.84	1.21	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	13.60	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	7.83	0.99	0.87	0.00
Myoblast, donor2	11322-117D8	7.29	2.30	2.11	0.38
Myoblast, donor3	11398-118D3	7.06	1.51	0.17	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	21.01	2.63	0.58	0.88
Natural Killer Cells, donor1	11230-116C6	20.30	8.92	4.31	0.00
Natural Killer Cells, donor2	11311-117C6	18.70	8.44	6.63	1.21
Natural Killer Cells, donor3	11387-118C1	22.82	7.73	8.28	0.00
Neural stem cells, donor1	11275-116H6	8.71	2.54	1.09	1.09
Neural stem cells, donor2	11352-117H2	13.48	0.00	0.00	0.00
Neurons, donor1	11494-119E9	9.10	0.00	0.00	2.28
Neurons, donor2	11574-120E8	8.59	0.66	0.00	1.10
Neurons, donor3	11655-122E8	1.64	0.00	0.00	1.64
Neutrophils, donor1	11233-116C9	57.54	12.06	10.21	0.93
Neutrophils, donor2	11314-117C9	49.28	5.80	14.49	0.00
Neutrophils, donor3	11390-118C4	87.35	11.00	18.33	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	9.26	2.97	0.00	1.66
Nucleus Pulposus Cell, donor2	11409-118E5	7.16	0.98	0.65	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	7.62	0.80	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	8.26	0.96	0.55	0.69
Olfactory epithelial cells, donor2	11934-125I8	11.87	2.03	1.45	0.00
Olfactory epithelial cells, donor3	11935-125I9	8.40	1.14	0.68	0.11
Olfactory epithelial cells, donor4	11936-126A1	8.86	2.05	1.46	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	10.23	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.74	1.49	0.21	0.85
Osteoblast - differentiated, donor2	11353-117H3	6.86	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	3.10	1.24	0.62	1.24
Osteoblast, donor1	11277-116H8	7.04	0.78	1.17	0.39
Osteoblast, donor2	11354-117H4	14.05	1.40	0.00	0.70
Osteoblast, donor3	11426-118G4	8.71	2.31	0.71	0.89
Pancreatic stromal cells, donor1	11249-116E7	9.10	2.86	1.10	0.76
Pericytes, donor1	11491-119E6	7.34	3.23	0.67	0.45
Pericytes, donor2	11571-120E5	8.83	4.07	0.68	0.91
Pericytes, donor3	11652-122E5	8.14	1.63	0.61	0.41
Perineurial Cells, donor1	11499-119F5	10.74	1.70	1.36	0.34
Perineurial Cells, donor2	11579-120F4	8.37	1.84	1.47	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	23.27	8.92	0.64	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	16.16	5.63	4.41	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	17.08	5.18	2.85	0.65
Placental Epithelial Cells, donor1	11278-116H9	10.76	2.63	3.35	0.24
Placental Epithelial Cells, donor2	11355-117H5	6.65	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	8.05	1.37	0.59	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.85	0.95	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	4.88	0.94	0.38	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	12.79	1.31	0.13	0.91
Preadipocyte - breast, donor2	11328-117E5	6.75	2.03	0.45	0.68
Preadipocyte - omental, donor1	11468-119C1	5.11	0.64	0.53	0.85
Preadipocyte - omental, donor2	11329-117E6	8.73	1.75	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	7.31	1.00	0.57	1.00
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.45	1.23	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	10.62	2.66	0.35	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	5.62	1.87	1.19	1.02
Preadipocyte - visceral, donor1	11280-116I2	9.78	2.14	1.21	0.75
Preadipocyte - visceral, donor2	11357-117H7	10.12	1.38	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	9.61	1.46	0.73	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	5.88	0.75	0.30	0.00
Prostate Epithelial Cells, donor2	11331-117E8	8.94	1.08	3.11	0.27
Prostate Epithelial Cells, donor3	11404-118D9	5.70	1.22	0.24	0.00
Prostate Stromal Cells, donor1	11254-116F3	10.36	2.28	0.80	0.91
Prostate Stromal Cells, donor2	11332-117E9	9.50	1.61	1.61	0.54
Prostate Stromal Cells, donor3	11405-118E1	11.99	3.13	1.15	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	11.68	1.09	0.73	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	6.45	1.66	0.55	0.55
Renal Epithelial Cells, donor1	11517-119H5	6.09	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.80	2.13	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	9.10	2.01	0.42	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	10.24	0.67	0.54	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.54	0.44	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	11.00	3.74	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	13.79	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	8.32	2.22	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	18.79	3.22	1.61	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.96	1.69	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.34	1.74	0.96	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	9.33	0.78	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	12.79	2.56	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	7.53	0.25	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.25	5.61	3.47	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	27.70	2.68	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	50.08	1.65	3.85	3.85
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	39.44	4.64	3.48	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	33.94	2.86	1.04	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.29	2.68	1.39	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	29.67	4.68	1.56	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	41.31	2.11	1.86	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.27	3.73	1.17	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	32.36	3.24	1.16	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	37.38	1.64	0.68	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.20	3.33	0.91	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	26.88	2.51	1.61	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	37.16	1.58	0.86	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	26.72	3.11	1.40	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	36.73	3.10	1.77	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	34.99	1.91	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.60	2.79	1.02	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.37	4.32	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	30.79	2.12	1.06	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	30.18	2.92	1.36	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	30.17	3.63	2.10	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	32.36	2.03	0.75	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.58	2.52	0.56	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	27.34	2.39	1.71	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	31.91	2.37	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	28.33	2.70	0.98	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	35.33	3.90	2.01	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	40.81	1.42	1.42	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	28.97	0.99	0.99	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	34.61	3.51	2.57	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	37.53	1.04	0.83	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	30.53	2.43	0.66	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	28.20	3.76	0.84	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	31.49	1.21	0.67	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	34.74	2.72	1.02	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	32.39	4.43	1.93	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	41.09	2.24	1.38	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.77	3.15	1.23	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	35.13	3.12	1.48	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	33.75	1.36	0.85	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	28.70	3.85	0.89	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.99	5.06	1.60	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	34.84	2.77	1.38	1.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	34.52	5.00	1.67	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	44.54	2.82	1.01	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	35.41	2.17	1.60	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.24	3.84	1.40	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	27.50	5.14	3.02	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	38.18	3.30	2.08	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	56.91	7.28	3.64	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.81	3.65	4.26	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	42.20	2.71	1.51	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	33.70	4.30	2.71	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	47.03	7.49	3.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	35.42	4.37	1.89	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	35.00	7.26	2.35	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	35.46	5.41	4.81	1.20
Schwann Cells, donor1	11498-119F4	9.97	2.07	0.56	0.94
Schwann Cells, donor2	11578-120F3	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.33	1.10	0.22	0.88
Sebocyte, donor1	11220-116B5	10.96	0.55	2.74	0.00
Sebocyte, donor2	11301-117B5	9.65	0.46	0.00	0.46
Sebocyte, donor3	11378-118B1	4.95	1.86	0.62	0.00
Sertoli Cells, donor1	11255-116F4	6.63	4.97	1.66	0.00
Sertoli Cells, donor2	11333-117F1	11.30	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.21	1.67	0.62	0.88
Skeletal Muscle Cells, donor2	11358-117H8	5.78	2.89	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	8.36	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	11.78	1.26	0.79	0.16
Skeletal Muscle Cells, donor5	11455-119A6	10.85	1.78	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	11.08	2.15	0.31	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	11.72	2.52	1.13	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	9.85	2.00	0.14	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	11.01	1.79	0.40	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	9.86	2.53	1.26	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.96	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.33	0.69	0.69	0.28
Skin - palm, donor1	10286-104F7	10.74	10.74	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	2.88	1.44	1.30	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	27.81	3.27	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.32	0.91	0.91	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	9.45	0.97	2.09	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	6.75	0.84	0.98	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	27.28	2.54	1.27	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	6.30	2.10	0.52	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.73	0.62	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.23	1.11	0.67	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.29	4.11	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	2.43	1.77	1.10	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	0.79	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	3.86	1.55	0.77	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	8.01	1.00	2.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.86	1.06	0.67	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.32	0.66	1.11	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.89	1.54	0.64	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.37	0.98	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	9.16	1.48	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.54	1.57	0.57	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.53	2.44	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.96	1.52	0.30	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	3.79	2.02	0.00	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.81	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	10.47	2.51	0.44	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.98	1.51	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	8.19	1.26	0.42	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	5.88	0.77	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	2.16	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.08	1.20	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.46	2.73	1.37	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	9.66	3.06	0.71	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	6.44	1.71	0.91	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	5.46	3.87	5.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	0.60	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	12.98	1.06	0.79	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.18	2.00	1.20	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	12.77	1.63	0.75	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.37	2.28	0.76	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7.09	1.81	0.60	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	1.50	0.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	2.58	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7.91	2.33	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.06	0.50	2.52	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.95	2.19	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.90	3.24	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	9.66	1.42	0.08	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	5.61	1.87	0.47	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.04	1.30	0.86	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.16	3.31	1.02	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.64	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	9.78	0.42	0.42	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.04	2.26	0.42	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.63	0.49	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.50	1.99	1.77	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	7.90	1.17	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.08	1.17	1.75	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.14	0.79	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	15.62	0.74	0.74	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	11.14	2.87	2.52	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.95	1.14	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.88	0.79	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	11.68	0.51	0.51	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	5.99	1.60	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	7.11	1.25	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	15.13	2.29	0.92	0.00
Synoviocyte, donor1	11291-117A4	7.24	2.69	2.36	1.18
Synoviocyte, donor2	11368-117I9	10.56	3.02	1.51	0.67
Synoviocyte, donor3	11440-118H9	8.71	2.46	0.22	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	14.29	2.14	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.49	0.93	0.46	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	9.25	1.65	1.58	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	9.28	1.93	1.93	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	22.39	6.40	3.94	0.98
Urethra, donor2	10319-105A4	25.18	3.60	10.79	3.60
Urothelial Cells, donor1	11520-119H8	7.70	2.13	0.80	0.00
Urothelial Cells, donor2	11600-120H7	5.21	2.40	2.40	0.00
Urothelial Cells, donor3	11681-122H7	5.04	2.06	0.69	0.00
Urothelial cells, donor0	11216-116B1	5.80	3.12	2.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	58.73	14.24	18.69	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	70.05	17.16	12.87	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.80	10.95	8.90	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	42.35	8.26	12.74	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	36.02	6.97	11.62	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	52.06	5.21	18.74	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	50.48	6.42	16.52	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	29.21	4.56	14.61	0.00
Wilms' tumor cell line:G-401	10809-111A8	8.64	1.36	0.12	1.11
Wilms' tumor cell line:HFWT	10597-108E3	7.92	0.88	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	19.27	5.31	5.31	1.12
achilles tendon, donor2	10292-104G4	22.73	4.13	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	12.75	1.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	15.79	2.32	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	18.64	0.95	0.00	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	26.67	1.63	0.00	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	28.39	1.12	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	33.63	4.23	0.85	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	16.88	3.27	0.54	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	17.18	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	40.43	3.68	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	37.66	1.55	0.39	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	14.72	0.37	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	27.89	1.86	0.23	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	32.88	1.81	0.52	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.17	1.46	0.58	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	22.77	1.86	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	29.61	2.88	1.23	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.81	0.31	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	30.30	2.13	0.43	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	35.49	1.82	0.00	3.03
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	31.53	1.20	0.48	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	22.50	0.67	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.01	2.67	2.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	3.72	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	45.58	5.65	6.03	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	19.19	0.87	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	3.75	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	16.25	3.06	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	21.41	6.67	6.20	0.62
adipose, donor1	10184-103D4	19.35	1.76	0.59	1.76
adipose, donor2	10185-103D5	3.65	0.41	0.41	1.22
adipose, donor3	10186-103D6	7.90	0.54	0.00	0.00
adipose, donor4	10187-103D7	7.80	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	16.73	0.32	0.00	3.16
adrenal gland, adult, pool1	10081-102A9	25.46	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	21.21	4.00	1.33	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.22	1.43	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	6.96	5.80	6.72	0.23
amniotic membrane cells, donor2	12236-129G4	5.07	3.38	1.69	0.34
amniotic membrane cells, donor3	12237-129G5	4.42	2.65	3.24	0.00
amygdala - adult, donor10196	10167-103B5	27.27	4.74	3.56	4.74
amygdala, adult, donor10252	10151-102I7	25.95	3.65	5.88	1.01
amygdala, newborn, donor10223	10360-105E9	17.75	1.29	3.23	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	9.42	4.20	1.27	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	13.46	1.99	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	6.35	1.67	0.00	0.67
aorta, adult, pool1	10052-101G7	28.44	9.02	2.75	1.37
appendix, adult	10189-103D9	20.57	3.49	5.05	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	18.57	1.38	2.41	0.69
artery, adult	10190-103E1	24.46	10.87	12.23	1.36
astrocytoma cell line:TM-31	10425-106D2	4.78	3.77	1.01	0.00
b cell line:RPMI1788	10427-106D4	5.50	1.64	0.45	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.99	2.77	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.50	0.60	0.69	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	8.03	2.01	1.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	26.28	1.12	1.12	0.56
bladder, adult, pool1	10011-101C2	14.23	5.11	3.15	0.87
blood, adult, pool1	10053-101G8	26.58	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	13.70	5.14	0.86	0.00
bone marrow, adult	10192-103E3	26.99	2.70	2.02	2.02
brain, adult, donor1	10084-102B3	23.58	3.08	2.05	1.03
brain, adult, pool1	10012-101C3	13.70	2.90	2.78	1.56
brain, fetal, pool1	10085-102B4	16.03	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	16.85	1.65	2.97	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	10.73	4.37	1.50	0.37
breast, adult, donor1	10080-102A8	12.00	3.16	4.42	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.70	2.79	1.02	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	10.20	3.09	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	10.82	1.38	0.00	4.37
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.24	2.18	2.18	0.48
carcinoid cell line:NCI-H1770	10703-109H1	14.58	0.47	0.47	1.41
carcinoid cell line:NCI-H727	10735-110B6	5.14	0.77	0.22	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	18.90	1.60	1.06	1.60
caudate nucleus - adult, donor10196	10177-103C6	28.78	1.15	6.91	2.30
caudate nucleus, adult, donor10252	10164-103B2	19.08	7.20	3.35	1.00
caudate nucleus, adult, donor10258	10379-105H1	11.46	7.64	2.29	1.53
caudate nucleus, newborn, donor10223	10354-105E3	12.82	1.10	1.46	1.46
cerebellum - adult, donor10196	10173-103C2	43.70	2.91	8.74	5.83
cerebellum, adult, donor10252	10166-103B4	30.53	19.64	9.39	2.35
cerebellum, adult, pool1	10083-102B2	20.01	5.17	2.07	1.03
cerebellum, newborn, donor10223	10357-105E6	49.82	9.96	11.62	2.49
cerebral meninges, adult	10188-103D8	10.34	2.27	3.03	1.01
cerebrospinal fluid, donor2	10294-104G6	9.50	0.73	2.92	0.73
cervical cancer cell line:D98-AH2	10552-107I3	7.62	0.86	0.00	0.72
cervical cancer cell line:ME-180	10553-107I4	15.58	3.81	6.30	0.00
cervix, adult, pool1	10013-101C4	16.90	7.66	2.10	2.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.12	1.53	0.84	1.95
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	2.61	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	14.04	0.99	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	14.66	0.25	0.12	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	29.41	0.24	0.24	1.19
chorionic membrane cells, donor1	12238-129G6	10.83	1.99	1.99	0.57
chorionic membrane cells, donor2	12239-129G7	14.12	1.79	1.99	0.60
chorionic membrane cells, donor3	12240-129G8	12.64	2.20	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	6.06	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	27.09	1.15	0.00	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.50	3.38	5.07	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	22.34	0.77	0.26	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	29.99	1.94	0.73	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	26.67	0.81	0.81	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	18.85	0.88	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	31.80	3.65	3.13	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	12.34	3.66	0.23	0.69
clear cell carcinoma cell line:TEN	10636-108I6	6.07	1.74	1.21	0.17
colon carcinoma cell line:CACO-2	10513-107D9	12.45	1.28	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	28.13	7.60	4.56	1.14
colon, adult, donor1	10082-102B1	26.18	2.38	1.19	1.19
colon, adult, pool1	10014-101C5	19.04	7.76	2.70	0.24
colon, fetal, donor1	10070-101I7	9.89	1.85	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.62	4.67	3.82	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	8.90	1.66	1.36	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	10.29	2.82	2.54	0.14
corpus callosum, adult, pool1	10042-101F6	26.09	8.07	2.65	3.10
cruciate ligament, donor2	10295-104G7	38.09	5.67	8.10	0.81
diaphragm, fetal, donor1	10069-101I6	18.46	5.62	8.83	0.00
diencephalon, adult	10193-103E4	12.72	3.36	1.68	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	12.63	0.46	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.21	7.44	5.39	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	10.83	1.20	0.48	0.48
ductus deferens, adult	10196-103E7	14.95	8.97	1.50	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	5.76	12.96	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	34.58	15.45	9.56	0.74
dura mater, adult, donor1	10041-101F5	65.08	9.41	7.52	2.31
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.43	1.11	0.67	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.19	0.43	0.14	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	13.57	4.32	4.93	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	7.57	3.63	1.21	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.34	4.01	8.03	0.00
embryonic pancreas cell line:2C6	10603-108E9	13.13	6.57	7.88	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	7.04	2.35	1.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	18.12	1.63	0.36	3.08
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	12.38	1.13	0.64	0.32
epidermoid carcinoma cell line:A431	10426-106D3	15.90	5.45	8.56	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	16.83	4.62	2.09	0.44
epididymis, adult	10197-103E8	23.65	8.58	2.72	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	9.40	0.89	0.71	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.54	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	17.17	2.88	2.23	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	15.55	2.07	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	18.71	3.25	2.02	0.22
esophagus, adult, pool1	10015-101C6	14.65	4.25	3.93	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	6.89	1.88	0.25	1.50
eye - muscle inferior rectus, donor1	10272-104E2	31.39	14.49	14.49	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	2.10	8.42	0.00
eye - muscle medial, donor2	10299-104H2	14.88	4.46	11.91	0.00
eye - muscle superior, donor2	10297-104G9	21.78	6.88	8.03	1.15
eye - vitreous humor, donor1	10268-104D7	17.49	2.91	2.91	0.00
eye, fetal, donor1	10054-101G9	6.86	2.54	1.02	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	4.10	0.64	0.00	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	13.06	1.42	0.47	0.95
frontal lobe, adult, pool1	10040-101F4	30.77	3.00	1.60	2.53
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.02	6.31	5.40	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	12.07	4.39	2.01	0.82
gall bladder, adult	10198-103E9	19.31	6.52	2.41	1.21
gamma delta positive T cells, donor1	11937-126A2	30.60	4.29	3.22	0.54
gamma delta positive T cells, donor2	11938-126A3	23.16	6.72	10.83	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	21.76	4.44	4.44	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	10.25	0.77	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	16.56	1.48	0.33	2.79
gastric cancer cell line:GSS	10560-108A2	10.07	1.83	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	13.02	1.14	2.51	1.14
giant cell carcinoma cell line:LU65	10487-107B1	3.56	0.69	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	5.60	2.10	0.56	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.47	3.49	3.49	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.03	3.38	0.95	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	10.25	2.25	2.11	0.14
glioblastoma cell line:T98G	10485-107A8	17.66	3.64	1.43	0.88
glioma cell line:GI-1	10413-106B8	5.27	1.17	0.00	0.88
globus pallidus - adult, donor10196	10175-103C4	24.78	3.64	3.64	0.00
globus pallidus, adult, donor10252	10161-103A8	25.63	11.47	3.66	1.22
globus pallidus, adult, donor10258	10367-105F7	10.95	1.37	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	7.99	2.13	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	44.05	9.79	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	5.44	2.56	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	11.94	0.00	0.46	1.38
hIPS +CCl2, biol_rep2	14384-156C1	9.15	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	7.09	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	15.81	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	14.40	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	16.55	2.21	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	8.05	0.86	0.86	0.57
heart - mitral valve, adult	10205-103F7	23.32	8.67	8.37	1.49
heart - pulmonic valve, adult	10206-103F8	30.07	7.58	2.88	1.83
heart - tricuspid valve, adult	10207-103F9	28.31	5.00	12.49	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	15.10	3.88	2.65	1.02
heart, adult, diseased, donor1	10051-101G6	18.74	4.26	0.85	0.00
heart, adult, pool1	10016-101C7	8.74	5.52	1.38	0.69
heart, fetal, pool1	10046-101G1	23.62	5.65	2.67	2.67
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.17	1.85	0.62	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	15.47	0.44	0.33	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	17.36	0.61	0.49	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	14.25	0.91	0.51	0.30
hepatoma cell line:Li-7	10484-107A7	4.78	0.67	0.22	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.75	0.00	0.00	0.20
hippocampus - adult, donor10196	10169-103B7	30.28	1.89	6.62	2.84
hippocampus, adult, donor10252	10153-102I9	19.80	7.96	4.49	1.63
hippocampus, adult, donor10258	10374-105G5	24.40	1.49	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	13.75	1.76	4.93	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.09	0.00	0.00	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.46	0.00	0.20	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	6.86	0.00	0.25	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	3.95	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.61	0.26	0.26	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	7.97	0.38	0.38	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	9.05	0.58	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	7.11	0.65	0.00	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.84	0.42	0.83	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.81	0.00	0.00	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	8.20	0.16	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	8.08	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	5.95	0.16	0.31	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.39	0.98	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	14.84	0.00	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	7.45	0.57	0.00	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	5.23	1.74	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.49	0.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	3.20	0.75	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.18	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.95	0.63	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.14	0.33	0.33	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.13	0.29	0.87	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	10.16	0.60	0.30	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	7.94	0.74	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	7.99	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	12.25	0.82	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	10.56	0.35	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	7.92	0.63	0.32	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	9.99	0.91	0.30	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	1.55	0.00	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	10.63	1.33	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.18	0.77	1.03	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.97	1.79	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.87	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.75	1.01	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	5.07	0.00	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	5.79	0.45	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.29	0.00	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	10.70	2.14	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	52.05	0.00	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	11.91	0.33	0.33	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.04	0.55	1.09	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	3.98	0.36	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	5.34	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	4.77	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	8.94	0.68	0.54	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.81	1.08	0.00	0.27
immature langerhans cells, donor1	11904-125F5	28.82	7.99	9.69	0.97
immature langerhans cells, donor2	11905-125F6	23.76	7.92	28.52	0.00
insula, adult, pool1	10039-101F3	32.08	3.31	2.65	3.22
keratoacanthoma cell line:HKA-1	10791-110H8	19.51	2.60	1.95	0.33
kidney, adult, pool1	10017-101C8	13.62	3.70	2.50	0.70
kidney, fetal, pool1	10045-101F9	17.90	5.09	2.55	1.63
large cell lung carcinoma cell line:IA-LM	10509-107D5	14.91	7.81	2.27	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.81	1.66	0.69	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	11.74	3.30	3.12	0.18
left atrium, adult, donor1	10079-102A7	22.34	1.63	0.54	0.00
left ventricle, adult, donor1	10078-102A6	9.61	0.51	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	9.85	1.37	0.82	0.82
leiomyoma cell line:10964C	10569-108B2	2.51	3.23	1.08	0.72
leiomyoma cell line:15242A	10570-108B3	7.07	0.54	1.63	1.09
leiomyoma cell line:15425	10571-108B4	6.56	1.46	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	16.73	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	31.29	2.95	1.77	0.24
liposarcoma cell line:KMLS-1	10782-110G8	11.72	3.91	1.25	0.94
liposarcoma cell line:SW 872	10726-110A6	9.14	3.29	0.61	0.24
liver, adult, pool1	10018-101C9	13.29	2.11	0.81	0.16
liver, fetal, pool1	10086-102B5	11.29	2.82	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.14	4.37	4.37	1.17
locus coeruleus, adult, donor10252	10165-103B3	18.46	5.54	5.35	0.74
locus coeruleus, adult, donor10258	10375-105G6	10.44	1.41	2.82	0.85
locus coeruleus, newborn, donor10223	10362-105F2	18.93	1.26	5.05	0.42
lung adenocarcinoma cell line:A549	10499-107C4	5.40	0.97	0.14	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	37.92	6.89	16.55	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	8.17	2.77	1.71	0.79
lung, adult, pool1	10019-101D1	17.13	5.32	3.43	0.35
lung, fetal, donor1	10068-101I5	34.25	11.13	7.71	3.14
lung, right lower lobe, adult, donor1	10075-102A3	29.33	6.87	6.42	0.46
lymph node, adult, donor1	10077-102A5	28.88	1.89	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	10.52	2.19	1.10	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	11.62	1.96	0.45	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	13.59	5.95	12.74	0.00
mature adipocyte, donor1	12231-129F8	20.87	7.55	5.77	0.89
mature adipocyte, donor2	12232-129F9	18.26	8.92	16.39	1.25
mature adipocyte, donor3	12233-129G1	18.73	12.80	15.88	0.71
mature adipocyte, donor4	12234-129G2	22.90	12.37	18.16	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	16.92	2.86	1.91	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	1.13	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	26.67	2.57	3.31	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	16.52	0.32	0.00	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	25.59	0.43	5.54	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	31.05	1.01	2.36	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	23.13	6.58	2.12	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	0.00	7.71	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	20.46	1.44	1.08	1.44
medulla oblongata - adult, donor10196	10174-103C3	24.01	1.30	5.84	1.95
medulla oblongata, adult, donor10252	10155-103A2	16.72	11.46	3.10	1.39
medulla oblongata, adult, pool1	10038-101F2	22.20	6.61	3.92	2.45
medulla oblongata, newborn, donor10223	10361-105F1	14.58	2.43	2.78	2.08
medulloblastoma cell line:D283 Med	10838-111E1	12.40	0.22	0.22	1.99
medulloblastoma cell line:ONS-76	10759-110E3	14.18	0.49	0.12	0.98
melanoma cell line:COLO 679	10514-107E1	11.07	1.58	0.43	0.29
melanoma cell line:G-361	10465-106H6	6.79	1.09	1.36	0.54
meningioma cell line:HKBMM	10691-109F7	3.08	2.17	1.09	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	7.93	1.76	0.00	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	8.81	0.78	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.81	1.23	0.15	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.63	1.09	0.36	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.56	1.24	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.29	1.26	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.35	2.70	0.96	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	2.78	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.75	0.51	0.51	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.48	1.50	0.58	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.42	1.06	0.53	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	9.18	1.62	0.95	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	8.39	1.71	0.57	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.59	0.99	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	6.64	0.97	0.83	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.38	3.49	0.70	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.96	2.25	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	6.83	0.36	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.31	2.59	1.45	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.89	0.91	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.43	1.26	2.10	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.67	2.09	0.45	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	8.05	1.23	0.35	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	6.63	4.05	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	5.72	2.86	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	11.79	1.26	0.42	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	0.46	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	8.70	0.51	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.38	1.05	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	5.85	0.92	0.92	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.30	1.88	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.49	0.34	1.02	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.07	0.79	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	10.66	0.93	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	13.84	1.73	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.59	1.34	0.89	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.69	1.20	0.72	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	14.67	3.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.03	1.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.42	1.64	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.73	1.72	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.32	0.65	1.30	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	0.00	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.27	0.78	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.30	2.37	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	0.00	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	0.63	1.27	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.28	1.03	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	6.89	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.70	2.04	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	1.59	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.72	2.95	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.36	2.81	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	2.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	1.18	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.70	4.13	2.07	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	1.48	3.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	2.24	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.18	1.91	2.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.90	1.61	2.42	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	4.36	10.90	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	5.07	3.80	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.92	1.82	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.88	1.65	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.13	1.79	0.99	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.36	3.24	1.62	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	3.06	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.19	4.64	2.32	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	14.41	3.78	1.65	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	16.91	7.41	5.79	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.47	1.64	3.29	0.31
mesothelioma cell line:Mero-25	10850-111F4	1.59	0.45	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	18.09	2.69	1.71	0.24
mesothelioma cell line:Mero-48a	10852-111F6	18.82	2.44	2.66	0.44
mesothelioma cell line:Mero-82	10853-111F7	8.41	1.84	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	9.36	2.55	1.36	0.34
mesothelioma cell line:Mero-84	10855-111F9	8.85	0.76	1.26	0.00
mesothelioma cell line:Mero-95	10856-111G1	9.73	2.07	1.04	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	8.45	1.16	0.50	0.50
mesothelioma cell line:NCI-H226	10846-111E9	9.77	1.27	1.45	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	11.79	2.73	1.88	0.68
mesothelioma cell line:NCI-H28	10845-111E8	9.92	1.53	0.25	1.02
mesothelioma cell line:No36	10857-111G2	6.20	0.65	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	8.94	1.63	2.17	0.27
migratory langerhans cells, donor1	11901-125F2	24.76	0.58	0.19	0.58
migratory langerhans cells, donor2	11902-125F3	27.96	1.10	0.24	0.37
migratory langerhans cells, donor3	11903-125F4	14.90	0.54	0.00	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.20	0.98	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	13.56	1.91	1.06	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.44	0.69	2.76	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.47	3.43	1.90	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	40.65	2.22	0.92	0.74
myeloma cell line:PCM6	10474-106I6	13.84	4.55	1.58	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	9.64	0.51	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.16	2.35	1.18	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.91	0.89	0.78	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.16	1.47	1.25	0.22
nasal epithelial cells, donor2	12227-129F4	9.94	2.21	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	3.22	0.46	0.00	1.38
neuroblastoma cell line:NB-1	10539-107G8	0.00	0.19	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	20.67	2.32	0.42	1.48
neuroblastoma cell line:NH-12	10555-107I6	8.20	0.37	0.56	2.42
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.47	0.47	0.24	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	8.24	0.48	0.16	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	15.70	0.20	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.17	0.00	0.00	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	8.25	0.27	0.27	0.53
neutrophil PMN, donor1	12133-128D9	0.00	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	18.94	3.38	0.34	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	3.20	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	13.14	2.89	1.60	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	18.92	3.42	2.10	0.79
nucleus accumbens, adult, pool1	10037-101F1	24.09	3.28	2.62	2.25
occipital cortex - adult, donor10196	10172-103C1	30.91	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	29.52	5.90	3.76	1.34
occipital cortex, newborn, donor10223	10355-105E4	16.01	0.73	2.55	1.09
occipital lobe, adult, donor1	10076-102A4	15.22	1.31	0.79	0.52
occipital lobe, fetal, donor1	10073-102A1	13.30	0.43	0.00	3.43
occipital pole, adult, pool1	10036-101E9	20.66	3.07	1.81	2.60
olfactory region, adult	10195-103E6	20.06	3.82	1.91	0.57
optic nerve, donor1	10277-104E7	14.01	8.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.40	2.96	5.24	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.17	2.89	1.37	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.24	3.05	2.88	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	8.20	1.27	0.69	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	7.94	1.47	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	13.08	3.74	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	43.26	6.15	2.97	1.27
ovary, adult, pool1	10020-101D2	12.14	5.59	2.80	1.83
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.62	2.57	0.55	0.37
pancreas, adult, donor1	10049-101G4	71.49	4.70	16.93	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	17.05	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	7.33	1.02	1.70	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.41	7.95	4.97	0.00
paracentral gyrus, adult, pool1	10035-101E8	21.51	2.84	2.56	1.56
parietal cortex, adult, donor10258	10373-105G4	18.35	3.67	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	21.63	0.94	1.88	1.88
parietal lobe, adult, donor10252	10157-103A4	24.80	4.56	0.86	2.00
parietal lobe, adult, pool1	10034-101E7	23.18	4.41	2.47	1.85
parietal lobe, fetal, donor1	10072-101I9	16.49	0.97	0.00	8.73
parietal lobe, newborn, donor10223	10356-105E5	13.83	0.75	3.74	2.24
parotid gland, adult	10199-103F1	9.87	4.32	7.40	0.62
penis, adult	10200-103F2	25.78	2.15	6.45	3.76
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	4.09	0.19	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	12.24	3.64	2.04	0.15
pineal gland - adult, donor10196	10179-103C8	21.93	1.29	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	26.65	5.33	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	28.22	3.14	0.63	3.76
pituitary gland - adult, donor10196	10180-103C9	17.20	3.04	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	41.69	10.94	1.56	4.69
pituitary gland, adult, donor10258	10378-105G9	17.88	3.40	0.85	0.85
placenta, adult, pool1	10021-101D3	15.37	5.27	4.52	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	10.20	2.38	0.26	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	10.43	2.65	0.31	1.40
pons, adult, pool1	10033-101E6	16.52	6.28	5.08	3.36
postcentral gyrus, adult, pool1	10032-101E5	20.05	2.18	1.57	1.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	23.01	4.18	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.47	1.60	0.87	1.02
prostate cancer cell line:PC-3	10439-106E7	19.42	5.26	2.54	0.54
prostate, adult, pool1	10022-101D4	12.79	7.89	2.00	1.09
putamen, adult, donor10196	10176-103C5	18.18	4.96	10.86	1.42
putamen, adult, donor10252	10152-102I8	5.88	7.84	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	12.02	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	13.53	2.66	1.69	0.72
putamen, newborn, donor10223	10365-105F5	17.24	1.50	3.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	11.93	1.16	1.16	0.00
rectum, fetal, donor1	10067-101I4	41.73	5.56	5.56	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	11.24	2.12	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.73	6.21	3.73	0.83
retina, adult, pool1	10030-101E3	25.84	6.06	3.98	3.18
retinoblastoma cell line:Y79	10475-106I7	6.50	0.00	0.00	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.57	1.11	0.00	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	23.06	7.59	0.56	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.91	5.30	2.27	0.00
salivary acinar cells, donor1	11771-123I7	8.90	2.75	1.29	0.16
salivary acinar cells, donor2	11772-123I8	9.78	2.75	1.51	0.55
salivary acinar cells, donor3	11773-123I9	13.24	6.62	0.00	0.00
salivary gland, adult, pool1	10093-102C3	13.73	7.44	2.86	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	7.42	1.52	0.34	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	7.05	1.65	0.24	0.71
seminal vesicle, adult	10201-103F3	12.70	5.29	2.12	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	25.51	3.64	8.99	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.32	2.01	1.76	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	5.02	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	12.49	2.82	3.22	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	10.61	2.10	0.55	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.39	2.58	1.94	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	15.61	7.09	9.22	0.00
skeletal muscle, adult, pool1	10023-101D5	11.03	3.48	3.48	0.96
skeletal muscle, fetal, donor1	10066-101I3	14.07	2.01	2.01	0.00
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	23.99	5.68	4.42	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	12.34	1.00	0.67	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	12.61	2.21	2.21	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	21.01	1.93	0.00	8.10
small cell lung carcinoma cell line:LK-2	10541-107H1	11.70	0.82	0.66	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	13.83	0.80	0.00	1.77
small cell lung carcinoma cell line:WA-hT	10562-108A4	15.91	3.27	3.70	0.87
small intestine, adult, pool1	10024-101D6	23.89	8.96	3.94	0.84
small intestine, fetal, donor1	10064-101I1	13.27	3.19	1.72	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	12.82	1.03	1.03	1.03
smooth muscle, adult, pool1	10048-101G3	14.99	3.88	2.58	0.26
somatostatinoma cell line:QGP-1	10781-110G7	6.70	1.61	0.54	0.80
spinal cord - adult, donor10196	10181-103D1	22.25	3.90	2.52	1.84
spinal cord, adult, donor10252	10159-103A6	23.26	5.13	1.18	0.79
spinal cord, adult, donor10258	10369-105F9	29.06	1.38	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	31.71	4.88	3.66	1.22
spinal cord, newborn, donor10223	10359-105E8	30.31	2.30	5.05	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	7.62	1.49	0.30	0.15
spleen, adult, pool1	10025-101D7	27.09	6.72	2.86	0.33
spleen, fetal, pool1	10044-101F8	37.82	6.36	5.40	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	8.70	1.86	0.41	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.77	3.99	4.18	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	18.87	2.80	9.44	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	21.89	3.52	5.47	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	10.69	1.91	1.24	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.56	3.81	3.39	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.04	0.42	0.00	0.42
stomach, fetal, donor1	10062-101H8	27.77	3.20	2.14	2.14
submaxillary gland, adult	10202-103F4	15.95	13.10	4.56	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	17.86	8.52	5.19	0.62
substantia nigra, adult, donor10258	10371-105G2	13.45	1.03	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	16.96	3.53	3.53	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	8.94	0.92	0.00	2.06
temporal lobe, adult, pool1	10031-101E4	22.63	3.73	1.44	2.20
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	12.82	0.00	0.71	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	13.19	0.44	0.00	2.20
tenocyte, donor1	11763-123H8	10.82	1.40	0.35	0.70
tenocyte, donor2	11765-123I1	10.68	4.58	0.76	0.00
tenocyte, donor3	11768-123I4	10.01	3.34	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	36.20	0.17	0.00	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	12.79	0.15	0.15	0.62
teratocarcinoma cell line:PA-1	10807-111A6	20.92	0.31	0.31	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	28.56	0.13	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	27.61	0.00	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	45.26	0.00	0.11	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.57	0.00	0.00	0.65
testis, adult, pool1	10026-101D8	14.50	3.33	2.25	0.97
testis, adult, pool2	10096-102C6	27.52	2.71	0.45	2.71
thalamus - adult, donor10196	10168-103B6	13.25	2.21	8.83	0.00
thalamus, adult, donor10252	10154-103A1	17.97	6.41	3.91	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.40	1.15	1.15	0.49
thalamus, newborn, donor10223	10366-105F6	8.63	1.15	1.73	0.58
throat, adult	10209-103G2	19.47	6.99	9.74	1.50
throat, fetal, donor1	10061-101H7	19.50	3.96	3.35	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	8.15	0.20	0.00	0.79
thymus, adult, pool1	10027-101D9	31.51	1.79	0.89	0.30
thymus, fetal, pool1	10043-101F7	70.45	3.64	4.05	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	12.50	1.99	1.86	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	11.87	1.82	0.14	1.40
thyroid, adult, pool1	10028-101E1	8.58	8.21	2.24	0.47
thyroid, fetal, donor1	10060-101H6	15.03	5.80	6.33	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	9.24	0.00	0.00
tongue, adult	10203-103F5	20.47	6.51	7.44	0.70
tongue, fetal, donor1	10059-101H5	13.01	4.34	3.55	1.58
tonsil, adult, pool1	10047-101G2	22.24	7.71	3.81	0.70
trachea, adult, pool1	10029-101E2	14.89	5.89	2.78	0.41
trachea, fetal, donor1	10058-101H4	17.70	5.00	3.46	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	9.57	3.19	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	19.15	2.13	2.13	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	18.65	4.07	1.25	1.25
tridermal teratoma cell line:HGRT	10694-109G1	19.03	1.90	1.90	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	9.65	1.86	0.85	0.17
umbilical cord, fetal, donor1	10057-101H3	20.87	0.00	4.17	2.09
uterus, adult, pool1	10100-102D1	29.35	5.63	3.24	1.02
uterus, fetal, donor1	10055-101H1	17.92	4.10	2.05	1.02
vagina, adult	10204-103F6	19.39	7.75	3.88	1.29
vein, adult	10191-103E2	22.80	6.58	4.38	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.88	2.94	1.34	0.27